These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16133686)

  • 1. Comparison of inhibitory effects of warfarin on gamma-carboxylation between bone and liver in rats.
    Hara K; Kobayashi M; Akiyama Y
    J Bone Miner Metab; 2005; 23(5):366-72. PubMed ID: 16133686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of bone osteocalcin levels on bone loss induced by ovariectomy in rats.
    Hara K; Kobayashi M; Akiyama Y
    J Bone Miner Metab; 2007; 25(6):345-53. PubMed ID: 17968486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K-dependent carboxylation of osteocalcin affects the efficacy of teriparatide (PTH(1-34)) for skeletal repair.
    Shimizu T; Takahata M; Kameda Y; Hamano H; Ito T; Kimura-Suda H; Todoh M; Tadano S; Iwasaki N
    Bone; 2014 Jul; 64():95-101. PubMed ID: 24731926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of warfarin and edoxaban, an oral direct factor Xa inhibitor, on gammacarboxylated (Gla-osteocalcin) and undercarboxylated osteocalcin (uc-osteocalcin) in rats.
    Morishima Y; Kamisato C; Honda Y; Furugohri T; Shibano T
    Thromb Res; 2013 Jan; 131(1):59-63. PubMed ID: 22999414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats.
    Haffa A; Krueger D; Bruner J; Engelke J; Gundberg C; Akhter M; Binkley N
    J Bone Miner Res; 2000 May; 15(5):872-8. PubMed ID: 10804016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopenia and bone-remodeling abnormalities in warfarin-treated lambs.
    Pastoureau P; Vergnaud P; Meunier PJ; Delmas PD
    J Bone Miner Res; 1993 Dec; 8(12):1417-26. PubMed ID: 8304041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K counteracts the effect of warfarin in liver but not in bone.
    Price PA; Kaneda Y
    Thromb Res; 1987 Apr; 46(1):121-31. PubMed ID: 3495903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet.
    Kobayashi M; Hara K; Akiyama Y
    Bone; 2004 Nov; 35(5):1136-43. PubMed ID: 15542039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased axial and peripheral bone density in patients taking long-term warfarin.
    Philip WJ; Martin JC; Richardson JM; Reid DM; Webster J; Douglas AS
    QJM; 1995 Sep; 88(9):635-40. PubMed ID: 7583077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of osteoblastic differentiation by warfarin and 18-α-glycyrrhetinic acid.
    Jeong HM; Cho DH; Jin YH; Chung JO; Chung MY; Chung DJ; Lee KY
    Arch Pharm Res; 2011 Aug; 34(8):1381-7. PubMed ID: 21910061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin K2 on cortical and cancellous bone mass and hepatic lipids in rats with combined methionine-choline deficiency.
    Iwamoto J; Seki A; Sato Y; Matsumoto H; Takeda T; Yeh JK
    Bone; 2011 May; 48(5):1015-21. PubMed ID: 21352961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
    Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects.
    Obrant KJ; Käkönen SM; Astermark J; Lilja H; Lövgren T; Akesson K; Pettersson K
    J Bone Miner Res; 1999 Apr; 14(4):555-60. PubMed ID: 10234576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli.
    Sugiyama T; Takaki T; Sakanaka K; Sadamaru H; Mori K; Kato Y; Taguchi T; Saito T
    J Endocrinol; 2007 Jul; 194(1):213-22. PubMed ID: 17592035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin-induced artery calcification is accelerated by growth and vitamin D.
    Price PA; Faus SA; Williamson MK
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):317-27. PubMed ID: 10669626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alfacalcidol on mechanical properties and collagen cross-links of the femoral diaphysis in glucocorticoid-treated rats.
    Saito M; Marumo K; Ushiku C; Kato S; Sakai S; Hayakawa N; Mihara M; Shiraishi A
    Calcif Tissue Int; 2011 Apr; 88(4):314-24. PubMed ID: 21327766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
    Brzóska MM; Moniuszko-Jakoniuk J
    Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis.
    Namba S; Yamaoka-Tojo M; Hashikata T; Ikeda Y; Kitasato L; Hashimoto T; Shimohama T; Tojo T; Takahira N; Masuda T; Ako J
    BBA Clin; 2015 Dec; 4():76-80. PubMed ID: 26674156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.